First Trust Advisors LP Has $8.13 Million Position in Medical Properties Trust, Inc. (MPW)
First Trust Advisors LP boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 6.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 631,905 shares of the real estate investment trust’s stock after buying an additional 35,835 shares during the period. First Trust Advisors LP owned 0.17% of Medical Properties Trust worth $8,133,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. IFP Advisors Inc increased its stake in shares of Medical Properties Trust by 15.1% in the first quarter. IFP Advisors Inc now owns 9,009 shares of the real estate investment trust’s stock valued at $116,000 after buying an additional 1,182 shares during the last quarter. Neuburgh Advisers LLC increased its stake in shares of Medical Properties Trust by 6.2% in the first quarter. Neuburgh Advisers LLC now owns 10,582 shares of the real estate investment trust’s stock valued at $136,000 after buying an additional 616 shares during the last quarter. Public Employees Retirement Association of Colorado bought a new stake in shares of Medical Properties Trust during the second quarter valued at approximately $147,000. Huntington National Bank increased its stake in shares of Medical Properties Trust by 70.1% in the first quarter. Huntington National Bank now owns 11,434 shares of the real estate investment trust’s stock valued at $147,000 after buying an additional 4,712 shares during the last quarter. Finally, Toronto Dominion Bank bought a new stake in shares of Medical Properties Trust during the first quarter valued at approximately $153,000. 85.55% of the stock is owned by institutional investors.
Shares of Medical Properties Trust, Inc. (NYSE MPW) opened at 12.81 on Monday. The firm has a market cap of $4.48 billion, a PE ratio of 15.66 and a beta of 0.89. The firm has a 50-day moving average of $12.75 and a 200 day moving average of $13.03. Medical Properties Trust, Inc. has a 52 week low of $11.54 and a 52 week high of $15.57.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.32. The business had revenue of $166.80 million during the quarter, compared to the consensus estimate of $163.08 million. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The business’s quarterly revenue was up 32.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.32 EPS. Equities research analysts predict that Medical Properties Trust, Inc. will post $0.86 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, September 14th will be paid a dividend of $0.24 per share. The ex-dividend date of this dividend is Wednesday, September 13th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.49%. Medical Properties Trust’s dividend payout ratio is currently 115.66%.
ILLEGAL ACTIVITY NOTICE: “First Trust Advisors LP Has $8.13 Million Position in Medical Properties Trust, Inc. (MPW)” was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://theolympiareport.com/2017/08/28/first-trust-advisors-lp-has-8-13-million-position-in-medical-properties-trust-inc-mpw.html.
Several analysts recently commented on MPW shares. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a report on Wednesday, July 19th. BidaskClub downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Deutsche Bank AG lifted their target price on shares of Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $16.00 target price on shares of Medical Properties Trust in a report on Monday, July 24th. Finally, ValuEngine downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company’s stock. Medical Properties Trust presently has a consensus rating of “Hold” and an average target price of $14.20.
In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the business’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total transaction of $1,135,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.00% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.